导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 19.00% | 40/72 |
| 近一周 | -1.29% | 11/76 |
| 近一月 | -3.46% | 61/75 |
| 近一季 | -4.53% | 54/74 |
| 近半年 | 3.60% | 72/74 |
| 近一年 | 21.87% | 32/72 |
| 近两年 | 39.94% | 48/68 |
| 近三年 | 31.79% | 31/40 |
| 成立以来 | 111.59% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
11.93% 9/74 |
1.21% 65/74 |
9.29% 64/74 |
- - |
| 2024 | 16.96% 39/75 |
-1.16% 61/67 |
10.01% 5/72 |
8.85% 19/74 |
-1.18% 47/75 |
| 2023 | -5.71% 33/72 |
3.61% 26/57 |
-4.95% 44/64 |
-1.37% 13/68 |
-2.94% 61/72 |
| 2022 | -4.95% 3/46 |
-8.71% 17/43 |
9.10% 1/45 |
-16.20% 38/45 |
13.88% 5/46 |
| 2021 | -19.69% 38/43 |
2.37% 121/312 |
-3.63% 294/328 |
-13.46% 251/358 |
-5.94% 34/43 |
| 2020 | 18.11% 25/41 |
-8.48% 104/280 |
15.23% 130/295 |
5.53% 89/299 |
6.13% 192/305 |
| 2019 | 25.24% 13/35 |
13.09% 72/258 |
-0.67% 195/268 |
0.51% 132/253 |
10.92% 50/266 |
| 2018 | -8.13% 7/31 |
- - |
- - |
- - |
-7.59% 90/241 |
| 2017 | 29.87% 10/30 |
- - |
- - |
- - |
- - |
| 2016 | 19.69% 2/31 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 国投瑞银中国价值发现股票 VS. () |